""
UC Davis Medicine Logo
The institution's principal publication for alumni, friends and physicians.
""
Horizontal boundary
""
""
"" "" ""
  F E A T U R E S  
"" "" ""
"" ""
"" "" ""
"" ""
"" "" ""
""  
"" "" ""
   
"" "" ""
   
"" "" ""
  Move Over R2D2  
Vertical Seperator Line
  FEATURES
"" ""
 
""

GENOME BUILDING LAUNCHES NEW ERA OF RESEARCH

 "" PHOTO — California Department of Insurance Commissioner John Garamendi was keynote speaker at the opening of the Genome and Biomedical Sciences Building, funded largely under the "Garamendi" mechanism. The legislation, sponsored in 1990 by then-state Sen. Garamendi, enables a state funding stream based on the premise that new research activities undertaken by the university produce overhead reimbursements from federal and other nonstate funds that can be used to fund building costs. The $95 million cost of the facility includes $65 million in Garamendi funds, as well as a $16 million contribution from the School of Medicine.
 
California Department of Insurance Commissioner John Garamendi was keynote speaker at the opening of the Genome and Biomedical Sciences Building, funded largely under the "Garamendi" mechanism. The legislation, sponsored in 1990 by then-state Sen. Garamendi, enables a state funding stream based on the premise that new research activities undertaken by the university produce overhead reimbursements from federal and other nonstate funds that can be used to fund building costs. The $95 million cost of the facility includes $65 million in Garamendi funds, as well as a $16 million contribution from the School of Medicine.
   

Focused on translating basic research discoveries into medical advances, more than 30 School of Medicine scientists are conducting their investigations in the new 225,000 square-foot UC Davis Genome and Biomedical Sciences Building. The researchers are from the following departments and divisions:

  • Medical Pharmacology and Toxicology
  • Medical Microbiology and Immunology
  • Physiology and Membrane Biology
  • Biochemistry and Molecular Medicine
  • Cardiovascular Medicine
  • Pulmonary and Critical Care Medicine
  • Endocrinology, Clinical Nutrition and Vascular Medicine
  • Rheumatology, Allergy and Clinical Immunology
  • Nephrology

Research projects under way include studies in infectious diseases, cancer, nutrition, neuroscience, pulmonary medicine and cardiovascular biology. Many involve the study of genes, their protein products, cell membranes, ion channels and other key cellular and molecular components that hold promise as targets for new drugs and preventive therapies. By applying innovative molecular technologies such as microarrays, genomics and nanoscience, researchers are better understanding the interaction among multiple genes, complex cellular processes and pathogens.

The facility will also boost the developing biotechnology and high-technology industry in the Sacramento region, through education, commercialization of research discoveries, outreach and other activities. Ultimately, these programs will provide benefits in human health, agriculture and the environment and continue UC Davis' long tradition of work in the service of the region and the state.

""
Vertical Seperator Line
"" "" ""
  The facility will also boost the developing biotechnology and high-technology industry in the Sacramento region, through education, commercialization of research discoveries, outreach and other activities.  
""   Vertical Seperator Line "" "" "" ""
"" "" Vertical Seperator Line
""
""

UC DAVIS SCHOOL OF MEDICINE
PUBLIC AFFAIRS
4900 Broadway, Suite #1200
Sacramento, CA 95820

ucdavismedicine@ucdmc.ucdavis.edu

© 2005 UC Regents. All rights reserved.

"" "" ""